The present invention provides novel methods for treating cerebrovascular
disorders, in which HGF is overexpressed by introducing an HGF gene. The
methods of this invention using an HGF gene enable active treatment of
cerebrovascular disorders, such as cerebral infarction, by gene transfer,
and enable the maintenance of neuronal function and the suppression of
infarcted areas in patients for whom appropriate treatment methods were
unavailable until now.